Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis
The Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis: A Randomized Active-Controlled Clinical TrialEvid Based Complement Alternat Med. 2021; 2021: 5596892.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Thirty-eight patients with knee osteoarthritis were randomized to receive 1 month of Harpagophytum procumbens treatment (n=18) or 10 days of daily meloxicam (n=20). Outcomes of interest included pain on a Visual Analog Scale (VAS), the Oxford Knee Scale (OKS) score, and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) score. Outcomes were assessed at 2, 4 and 8 weeks follow up...
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.Continue